Latest News & Updates

Breaking News

  • 10 hours ago

  • Simantini Singh Deo

KIHT Gains Government Approval to Conduct Clinical Research for Drugs and Medical Devices in India
Breaking News
Indian Pharmacopoeia Commission Convenes Conclave to Shape IP 2026 Compliance and Quality Standards

Simantini Singh Deo

Other trending news you may like to read

KIHT Gains Government Approval to Conduct Clinical Research for Drugs and Medical Devices in India

KIHT receives government approval to operate as a CRO for drugs and medical devices, expanding India's clinical research capacity.

Simantini Singh Deo

Pharma Now

Indian Pharmacopoeia Commission Convenes Conclave to Shape IP 2026 Compliance and Quality Standards

IPC's IP 2026 conclave signals tightening compliance timelines for manufacturers in and exporting to India.

Simantini Singh Deo

Pharma Now

India Targets US$130 Billion Pharma Market and US$80 Billion in Exports by 2030, ASSOCHAM Projects

ASSOCHAM projects India's pharma market at US$130B and exports at US$80B by 2030, with biosimilars, biologics, and regulatory harmonization as key drivers.

Simantini Singh Deo

Pharma Now

Ascendis Pharma Achieves Five-Year Phase 2 Efficacy Data for TransCon PTH in Hypoparathyroidism

Ascendis Pharma's five-year Phase 2 data for TransCon PTH show 82% response rates, signaling imminent manufacturing scale-up and GMP compliance challenges.

Simantini Singh Deo

Pharma Now